JPS6248611A - External preparation for skin - Google Patents
External preparation for skinInfo
- Publication number
- JPS6248611A JPS6248611A JP60187188A JP18718885A JPS6248611A JP S6248611 A JPS6248611 A JP S6248611A JP 60187188 A JP60187188 A JP 60187188A JP 18718885 A JP18718885 A JP 18718885A JP S6248611 A JPS6248611 A JP S6248611A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- external preparation
- anthocyanins
- anthocyanidins
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、アントシアニン類及び/又はそのアグリコン
であるアンドシアニジン類を含む皮膚外用剤に関する。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to an external preparation for skin containing anthocyanins and/or their aglycones, andocyanidins.
本発明に係る皮膚外用剤は、皮膚になめらかさ及びしっ
とり感を与え、つやとはりのあるきめこまかな美しい肌
にする作用を有し、更に皮膚血液循環を改善する効果も
併せもつ新規な皮膚外用剤である。The skin external preparation according to the present invention is a novel skin external preparation that has the effect of making the skin smooth and moisturized, making the skin glossy, firm, fine-grained, and beautiful, and also has the effect of improving skin blood circulation. It is a drug.
従来の技術
アンドシアニン類またはそれらのアグリコンであるアン
トシアニジン類はともに天然植物に含まれる公知の物質
であり、例えば食品用着色料として使用されている。BACKGROUND OF THE INVENTION Andocyanins and their aglycones, anthocyanidins, are both known substances contained in natural plants, and are used, for example, as food coloring agents.
従来、アントシアニン類は植物の花又は果実から抽出し
、精製して得ていたが、最近植物細胞培養の技術の進歩
により工業的に一定の品質のものが得られるようになっ
た。また天然物から得られるアントシアニン類には、安
定性や安全性の面から好ましからざる混在物が多く含有
されており、かかる混在物を除去してアントシアニンを
精製するのに多大なコストが必要であったが、前記した
培養法により得られるアンドシアニンはこの点において
極めて純粋で優れている。Conventionally, anthocyanins were obtained by extracting and purifying the flowers or fruits of plants, but with recent advances in plant cell culture technology, it has become possible to obtain products of a certain quality industrially. In addition, anthocyanins obtained from natural products contain many contaminants that are undesirable from the standpoint of stability and safety, and it requires a large amount of cost to remove such contaminants and purify anthocyanins. However, the andocyanin obtained by the above-mentioned culture method is extremely pure and excellent in this respect.
発明が解決しようとする問題点
本発明者らは、皮膚に対して特徴的な有効性又は有用性
、例えば肌荒れ改善効果、角質改善効果等を有する天然
物質を得るべく、鋭意研究を進めた結果、アントシアニ
ン類及びそのアグリコンであるアントシアニジン類が、
これらを皮膚外用剤の基剤に配合することにより、前記
目的を達成し得ることを見い出した。Problems to be Solved by the Invention The present inventors have conducted intensive research to obtain natural substances that have characteristic efficacy or usefulness for the skin, such as improving rough skin and improving keratin. , anthocyanins and their aglycones, anthocyanidins,
It has been found that the above object can be achieved by incorporating these into the base of an external skin preparation.
更にアントシアニン類及びアントシアニジン類の中で、
ユーホルビア屈植物ハナキリンの細胞培養によって得た
クリサンテミン及び/またはそのアグリコンであるシア
ニジンが特に優れた作用を有することを見い出し、また
皮膚外用剤として使用可能な紫外線吸収剤及び/または
酸化防止剤を配合することにより耐光性を向上させるこ
とにも成功し本発明を完成するに至った。Furthermore, among anthocyanins and anthocyanidins,
It has been discovered that chrysanthemine and/or its aglycone cyanidin obtained by cell culture of the Euphorbia genus Hanakirin have particularly excellent effects, and they have also been formulated with ultraviolet absorbers and/or antioxidants that can be used as external preparations for the skin. As a result, they succeeded in improving the light resistance and completed the present invention.
問題点を解決するための手段及びその作用即ち、本発明
従えば、アントシアニン類及びそのアグリコンであるア
ントシアニジン類の群から選ばれた少なくとも1種を、
特に好ましくはユーホルビア属植物ハナキリンの培養細
胞から得られるクリサンテミン及び/またはシアニジン
を、0.0001〜30重量%、好ましくはo、oos
〜20重量%を含有する皮膚外用剤が提供される。According to the present invention, at least one member selected from the group of anthocyanins and anthocyanidins which are aglycones thereof,
Particularly preferably, 0.0001 to 30% by weight, preferably o, oos, of chrysanthemine and/or cyanidin obtained from cultured cells of Euphorbia plant Hanakirin
A skin external preparation containing ~20% by weight is provided.
本発明に従った皮膚外用剤には、前述の如く、アントシ
アニン類又はそのアグリコンであるアントシアニジン類
を、好ましくは0.0001〜30重量%配合すること
によって以下の実施例にも説明するように、皮膚になめ
らかさ及びしっとり感を与え、つやとはりのあるきめこ
まやかな美しい肌にする作用を有し、更に皮膚血液循環
を改善する効果が得られる。As described above, the skin external preparation according to the present invention preferably contains 0.0001 to 30% by weight of anthocyanins or their aglycones, anthocyanidins, as described in the following examples. It has the effect of imparting smoothness and moisture to the skin, making the skin glossy, firm, fine-textured and beautiful, and also has the effect of improving skin blood circulation.
本発明において使用するアントシアニン類としては、例
°えばクリサンテミン、ベラルゴニン、シアニン、メコ
シアニン、デルフィニン、ベツニンカ挙ケられ、またア
ンドシアニジン類としては、例えばシアニジン、ベラル
ゴニジン、デルフィニジン、ベオニジン、ベツニジン、
マルビジンなどを挙げることができる。Examples of the anthocyanins used in the present invention include chrysanthemine, belargonin, cyanin, mecocyanin, delphinin, and betunin, and examples of the andocyanidins include cyanidin, belargonidin, delphinidin, beonidin, betunidin,
Examples include malvidin.
これらのアントシアニン類及びアントシアニジン類とし
ては、例えば高等植物に属するユーホルビア属植物ハナ
キリンの培養細胞から得られるクリサンテミン、シアニ
ジンを好適に使用することができ、かかる方法でクリサ
ンテミン及びシアニジンを得るには、例えば特開昭57
−2696号公報、特開昭57−2697号公報、特開
昭57−14653号公報、特開昭57−18983号
公報、などに記載の方法によって製造することができる
。As these anthocyanins and anthocyanidins, for example, chrysanthemine and cyanidin obtained from cultured cells of Hanakirin, a plant belonging to the genus Euphorbia, which belongs to higher plants, can be suitably used. 1977
It can be produced by the methods described in JP-A-2696, JP-A-57-2697, JP-A-57-14653, JP-A-57-18983, and the like.
本発明の皮膚外用剤に配合するアントシアニン類及び/
又はアントシアニジン類の配合量には特に限定はないが
、前述の如く、0.0001〜30重量%配合するのが
好ましい。アントシアニン類及び/又はアントシアニジ
ン類の配合量が少な過ぎると本発明の効果が得られない
ので好ましくなく、逆に多過ぎると皮膚外用剤としての
製剤が困難であり、また皮Jf、着衣等への着色が著し
いので好ましくない。Anthocyanins and/or compounded in the skin external preparation of the present invention
The amount of anthocyanidins to be blended is not particularly limited, but as mentioned above, it is preferably blended in an amount of 0.0001 to 30% by weight. If the amount of anthocyanins and/or anthocyanidins is too small, the effect of the present invention cannot be obtained, which is undesirable.On the other hand, if the amount is too large, it is difficult to formulate it as an external preparation for the skin, and it may not be suitable for skin, clothing, etc. It is not preferred because the coloration is significant.
本発明の皮膚外用剤には、上記必須成分に加えて、紫外
線吸収剤を配合することができる。かかる紫外線吸収剤
としては、例えば2−ヒドロキシ4−メトキシベンゾフ
ェノン5−スルホン酸すl・リウム(ASL−243)
、パラジメチルアミノ安息香酸メチル(エス力ロール5
06)ウロカニン酸、2−ヒドロキシ−4−メトキシベ
ンゾフェノン、2.2’−ジヒドロキシ4.41−ジメ
トキシベンゾフェノン等の皮膚外用剤に使用可能な紫外
線吸収剤をあげることができる。かかる紫外線吸収剤の
使用量には特に限定はないが、好ましくは0.001〜
5重量%、更に好ましくは0.1〜2重量%含ませるこ
とができる。In addition to the above-mentioned essential ingredients, the external skin preparation of the present invention may contain an ultraviolet absorber. Such ultraviolet absorbers include, for example, 2-hydroxy 4-methoxybenzophenone 5-sulfonate sulfonate (ASL-243).
, methyl p-dimethylaminobenzoate (S-Riki Roll 5
06) Ultraviolet absorbers that can be used in external skin preparations include urocanic acid, 2-hydroxy-4-methoxybenzophenone, and 2,2'-dihydroxy-4,41-dimethoxybenzophenone. There is no particular limitation on the amount of the ultraviolet absorber used, but it is preferably from 0.001 to
It can be contained in an amount of 5% by weight, more preferably 0.1 to 2% by weight.
本発明に従った皮膚外用剤には、更に、酸化防止剤を配
合することができる。そのような酸化防止剤としては、
例えばビタミンE1タンニン酸、没食子酸、ブチルヒド
ロキシアニソール、エリソルビン酸等の皮膚外用剤に使
用可能な酸化防止剤を挙げることができる。これらの酸
化防止剤の配合量にも特に限定はないが、好ましくは0
.001〜5重量%、更に好ましくは0.O1〜2重量
%配合することができる。The skin external preparation according to the present invention may further contain an antioxidant. Such antioxidants include:
For example, antioxidants that can be used in external skin preparations include vitamin E1 tannic acid, gallic acid, butylated hydroxyanisole, and erythorbic acid. There is no particular limitation on the amount of these antioxidants, but it is preferably 0.
.. 0.001 to 5% by weight, more preferably 0.001 to 5% by weight. 1 to 2% by weight of O can be blended.
本発明の皮膚外用剤には、更に、必要に応じ、皮膚外用
剤のタイプに応じて、油分、水、界面活性剤、保湿剤、
低級アルコール、増粘剤、香料、キレート剤、色素、防
腐防黴剤などの皮膚外用剤に一般に用いられる成分を配
合することができる。The external skin preparation of the present invention may further contain oil, water, surfactants, humectants, etc., depending on the type of external skin preparation, if necessary.
Ingredients commonly used in external skin preparations such as lower alcohols, thickeners, fragrances, chelating agents, pigments, and antiseptic agents can be blended.
また本発明の剤型は任意であり、溶液系、油分系、乳化
系、粉末分散系、水−油二層系、水−油一粉末三層系等
のような剤型でも構わな、い。Further, the dosage form of the present invention is arbitrary, and may be a solution type, an oil type, an emulsion type, a powder dispersion type, a water-oil two-layer system, a water-oil one-powder three-layer system, etc. .
更に本発明の皮膚外用剤の用途も任意であり、化粧水、
乳液、クリーム、パック等のフェーシャル化粧品やヘア
トニック、ヘアリキッド等の頭髪化粧品はもちろん、フ
ァンデーション、口紅、アイシャドー等メーキャップ化
粧品やボディ化粧品に用いることができる。Furthermore, the use of the skin external preparation of the present invention is arbitrary, and it can be used as a lotion,
It can be used not only in facial cosmetics such as emulsions, creams, and packs, and hair cosmetics such as hair tonics and hair liquids, but also in makeup cosmetics and body cosmetics such as foundations, lipsticks, and eye shadows.
実施例
以下、実施例に従って本発明を更に詳細に説明するが、
本発明の技術的範囲をこれらに限定するものでないこと
はいうまでもない。EXAMPLES Hereinafter, the present invention will be explained in more detail according to examples.
It goes without saying that the technical scope of the present invention is not limited to these.
なお、以下の例において配合量は重量%を示す。In addition, in the following examples, the blending amount indicates weight %.
実施例1
(配合)
成分 %■グリセリ
ン 5.0■クエン酸
0.03■クエン酸
ソーダ 0.05■アラン
トイン 0.1■エタノー
ル(95%) 10.0■POE
(15モル)オレイルエーテル 1.0■クリサン
テミン $1 0.5■ASL−2
430,3
■香料 O0■[相
]防腐剤 0.10色
素 通量@精製水
残余*1特開昭57−
2696号公報、特開昭57−2697号公報、特開昭
57−14653号公報及び特開昭57−18983号
公報記載の方法に得られるクリサンテミン。以下実施例
では同様にして得たクリサンテミンを使用した。Example 1 (Formulation) Ingredients % Glycerin 5.0 Citric acid
0.03■Sodium citrate 0.05■Allantoin 0.1■Ethanol (95%) 10.0■POE
(15 mol) Oleyl ether 1.0 ■ Chrysanthemine $1 0.5 ■ ASL-2
430,3 ■Fragrance O0 ■[Phase] Preservative 0.10 Colorant Usage @ Purified water
Remaining *1 JP-A-57-
Chrysanthemine obtained by the methods described in JP-A-2696, JP-A-57-2697, JP-A-57-14653 and JP-A-57-18983. In the following examples, chrysanthemine obtained in the same manner was used.
(製法)
上記成分■、■、■及び[相]を室温にて混合溶解し、
同じく室温にて混合熔解した成分■、■、■、■、■、
■、■及び@中へ攪拌添加して化粧水を得た。(Production method) Mix and dissolve the above components ■, ■, ■ and [phase] at room temperature,
Similarly, the components mixed and melted at room temperature■,■,■,■,■,
A lotion was obtained by stirring and adding to the contents of ①, ② and @.
一方、上記実施例1の配合から■クリサンテミンを除い
た以外は全て実施例1と同様にして比較例1の化粧水を
得た。On the other hand, a lotion of Comparative Example 1 was obtained in the same manner as in Example 1 except that (1) chrysanthemin was removed from the formulation of Example 1 above.
(評価試験)
(1)実施例1および比較例1の化粧水について、女性
パネル20名により使用テストを行った。すなわち実施
例1および比較例1の化粧水苔0.5−を左右前腕部内
側に1日2回、3力月間連続通用し、その効果について
パネルに対するアンケート調査を行ない、肌のなめらか
さ及びしっとり感について、パネル自身に、有効、やや
有効、無効の3段階で評価してもらった。(Evaluation Test) (1) A use test was conducted on the lotions of Example 1 and Comparative Example 1 by a panel of 20 women. In other words, the lotion moss 0.5 of Example 1 and Comparative Example 1 was applied to the inside of the left and right forearms twice a day for three months, and a questionnaire survey was conducted on a panel to determine the effect. The panel asked them to rate their feelings on a three-point scale: effective, somewhat effective, and ineffective.
結果は第1表に示す通りであった。The results were as shown in Table 1.
(2)肌のつや、はりについては、パネルの皮膚(実施
例1通用部)の弾性率を比較例のそれと同様に測定し比
較した。(2) Regarding skin gloss and firmness, the elastic modulus of the panel skin (example 1 common area) was measured and compared in the same manner as that of the comparative example.
結果は第2表に示す通りであった。The results were as shown in Table 2.
(3)通用部位の皮膚血流量について、レーザードツプ
ラー血流針を用いてパネルの実施例1の化粧水通用部と
比較例1の化粧水通用部を測定し、比較した。(3) Regarding the skin blood flow in the application area, the skin lotion application area of Example 1 and the application area of Comparative Example 1 of the panel were measured and compared using a laser Doppler blood flow needle.
結果は第3表に示す通りであった。The results were as shown in Table 3.
(4)動物実験
マウス(ICR−JCL系雄、体重21〜24g)の背
部の毛を刈り、実施例1および比較例1の化粧水を0.
2−7日で2力月間連続して背部皮膚に塗布した。(4) Animal experiment The hair on the back of a mouse (ICR-JCL male, weight 21-24 g) was shaved, and the lotions of Example 1 and Comparative Example 1 were applied at 0.00%.
It was applied to the back skin continuously for 2 to 7 days for 2 months.
塗布終了日から24時間後に背部皮膚を採取し、その中
のヒアルロン酸量を測定した(ムコ多糖実験法(I)、
1972.31頁〜125頁参照)。24 hours after the end of application, the back skin was collected and the amount of hyaluronic acid therein was measured (Mucopolysaccharide Experimental Method (I),
1972, pp. 31-125).
結果は第4表に示す通りであった。The results were as shown in Table 4.
(以下余白)
第1表
評 価 項 目 実施例1 比較例1肌のなめ
らかさ
有効 15/ 20 1/ 20やや有
効 5/ 20 2/ 20無効
0/ 20 1.7/ 20肌のしっとり感
有効 16/ 20 0/ 20やや有
効 4/ 20 3/ 20無効
0/ 20 17/ 20以上の結果から実施例
1を適用した部位の皮膚状態は明らかに改善されている
ことを確認した。なお皮膚状態が悪化した例はなかった
。(Margin below) Table 1 Evaluation Item Example 1 Comparative Example 1 Skin smoothness effective 15/20 1/20 Slightly effective 5/20 2/20 Ineffective
0/ 20 1.7/ 20 Moist skin effect effective 16/ 20 0/ 20 Slightly effective 4/ 20 3/ 20 Ineffective
0/20 17/20 From the above results, it was confirmed that the skin condition at the site where Example 1 was applied was clearly improved. There were no cases where the skin condition worsened.
(以下余白)
第2表
パネル 弾性率 γ (dyne (2) ×
10°)実施例1 比較例1 対照(無
駆 年齢 通用部位 通用部位 処理部位)12
0 2.4 3.1 3.1231
2.5 2.6 2.7336
3.0 3.3 3.3424 1.
7. 1゜81.8522 1.6 1
.7 1.6624 1゜? 2.1
2.1?381.7 1゜81.7
840 3.3 3.4 3.694
5 1.6 1.8 1.91042
2.0 2.1 2.11!29
1.3 1.4 1.41235
1.4 1.5 1.51334
2.6 3゜13.01438 3.0
3.4 3.21521 1.6
1.7 1.71627
2.2 2.3 2.2173
6 2.3 2.6 2
.71B20 1.2 1.3
1.21937 2.5
3.0 3.02040 3.4
3.5 3.5平均値 2
.17 2.38 2.37以上の結果から明
らかなように、実施例1の化粧水を通用した部位の皮膚
弾性率は低下しており、皮膚のはりが増加していること
が確認された。(Margin below) Table 2 Panel Elastic modulus γ (dyne (2) ×
10°) Example 1 Comparative Example 1 Control (Nondrive, age, common site, common site, treated site) 12
0 2.4 3.1 3.1231
2.5 2.6 2.7336
3.0 3.3 3.3424 1.
7. 1゜81.8522 1.6 1
.. 7 1.6624 1°? 2.1
2.1?381.7 1°81.7 840 3.3 3.4 3.694
5 1.6 1.8 1.91042
2.0 2.1 2.11!29
1.3 1.4 1.41235
1.4 1.5 1.51334
2.6 3゜13.01438 3.0
3.4 3.21521 1.6
1.7 1.71627
2.2 2.3 2.2173
6 2.3 2.6 2
.. 71B20 1.2 1.3
1.21937 2.5
3.0 3.02040 3.4
3.5 3.5 average value 2
.. 17 2.38 2.37 As is clear from the above results, the skin elastic modulus of the area where the lotion of Example 1 was applied decreased, and it was confirmed that the firmness of the skin increased.
第3表
実施例1通用部/ 比較例1/
患 年齢 対照部位×100 対照×100
平均±SD 112.5±9.1 98.9
±4.3以上の結果から明らかなように、実施例1の化
粧水通用部位の皮膚血流量が比較例1の化粧水適用部位
に比較して増加していることが確認された。この原因に
ついては必須成分クリサンテミンによる血管拡張作用が
考えられた。なお、実際にウサギ摘出動脈に対してクリ
サンテミンは拡張作用を示した。Table 3 Example 1 Common area / Comparative example 1 / Affected age Control area x 100 Control x 100
Mean±SD 112.5±9.1 98.9
As is clear from the results of ±4.3 or more, it was confirmed that the skin blood flow in the area where the lotion was applied in Example 1 was increased compared to the area where the lotion was applied in Comparative Example 1. The cause of this was thought to be the vasodilatory effect of the essential ingredient chrysanthemine. Furthermore, chrysanthemin actually showed a dilating effect on isolated rabbit arteries.
ヒアルロン酸量(%)
試 料 ヒアルロン酸/全ムコ多糖×10゜n=
10 平均上標準偏差
対照(無処理”) 38.0土5.2実施例
1 45.3±2.5比較例1
39.1±2.8以上の結果から明らかなよう
に、実施例1の化粧水は対照(無処理)および比較例1
に対し危険率1%以下で有意(を検定)に皮膚ヒアルロ
ン酸量を増加させることが判明した。Hyaluronic acid amount (%) Sample Hyaluronic acid/Total mucopolysaccharides x 10゜n=
10 Standard deviation above the mean Control (untreated) 38.0 Soil 5.2 Example 1 45.3 ± 2.5 Comparative example 1
As is clear from the results of 39.1±2.8 or more, the lotion of Example 1 was better than the control (untreated) and Comparative Example 1.
It was found that the amount of hyaluronic acid in the skin was significantly increased (tested) with a risk rate of 1% or less.
第1表〜第3表の結果と併せ考察すると、肌のなめらか
さ、しっとり感、皮膚弾性率に関して皮膚に好ましい効
果が明らかになった1つの原因として皮膚ヒアルロン酸
量の増加が考えられる。When considered together with the results in Tables 1 to 3, an increase in the amount of hyaluronic acid in the skin is considered to be one of the reasons why the favorable effects on the skin regarding skin smoothness, moist feeling, and skin elasticity were revealed.
ヒアルロン酸量の増加について、その機構は明確ではな
いが、本発明の必須成分の1つであるクリサンテミンが
ヒアルロン酸分解酵素に対し抑制的に作用することを本
発明者らは確認しており、このことが1つの要素となっ
ている可能性が推察された。Although the mechanism for increasing the amount of hyaluronic acid is not clear, the present inventors have confirmed that chrysanthemin, one of the essential ingredients of the present invention, has an inhibitory effect on hyaluronic acid degrading enzymes. It was speculated that this may be a factor.
次に本発明の要素となっているクリサンテミンの光に対
する安定性向上についてその実験例を示す。Next, an experimental example will be shown to improve the stability against light of chrysanthemine, which is an element of the present invention.
試料に50℃の環境下でキセノンランプにより光を照射
しく461 X104 J/rd> 、5時間及び30
時間後最大吸収波長(λa+ax )における吸光度を
測定した。The sample was irradiated with light using a xenon lamp in an environment of 50°C for 461 x 104 J/rd>, 5 hours and 30
After a period of time, the absorbance at the maximum absorption wavelength (λa+ax) was measured.
結果を第5表に示した通りである。The results are shown in Table 5.
(以下余白)
第5表
λ+maxにおける吸光度
試 料 残存率%Ohr
5 hr 30hr
■クリサンデミ20.5%水溶液 100
42.6 8.0■クリサンテミン0.5%十〇C0−
60 (1%’) 100 24.7 2.4■ ■
+ASL−24S (0,3%”) 100
90.9 73.4■ ■十エスカロール506
(0,5%) 100 91.4 75.7■
■+ASL−24S (0,3%”) 10
0 90.5 54.1■ ■十没食子酸(1%)
100 65.8 47.1■ ■十没
食子酸(1%) 100 56.1
32.4■ ■+ASL−243(0,3%) +
100 95.4 80.7没金子酸(1%)
■ ■+A S L−243(0,3%’) +
100 92.7 76.1没金子酸(1%)
以上のようにクリサンテミン単独あるいは界面活性剤を
添加した試料は退色が著しかったが、紫外線吸収剤及び
/または酸化防止剤を添加することにより、光による退
色を極めて良好に改善できた。(Left below) Table 5 Absorbance sample at λ+max Remaining rate %Ohr
5 hr 30hr ■Chrysandemi 20.5% aqueous solution 100
42.6 8.0 ■ Chrysanthemine 0.5% 〇C0-
60 (1%') 100 24.7 2.4 ■ ■
+ASL-24S (0.3%”) 100
90.9 73.4 ■ ■ Ten Escarole 506
(0.5%) 100 91.4 75.7■
■+ASL-24S (0.3%”) 10
0 90.5 54.1■ ■ Ten gallic acid (1%)
100 65.8 47.1■ ■ Ten gallic acid (1%) 100 56.1
32.4■ ■+ASL-243 (0.3%) +
100 95.4 80.7 Gallic acid (1%) ■ ■+A S L-243 (0.3%') +
100 92.7 76.1 Galvanic acid (1%) As mentioned above, samples with chrysanthemin alone or with surfactant added showed significant discoloration, but by adding ultraviolet absorber and/or antioxidant, The fading caused by light could be improved very well.
実施例2
(配合)
成分 %■グリセリ
ン 5.00ポリエチレン
グリコール(分子量400 ) 2.0■グリチルリ
チン酸モノアンモニウム塩 0.1■アラントイン
0.10クリサンテミン
1.0■セタノール
4.00スクワラン
5.0■ステアリン酸
1.0■ミツロウ
1.0[相]ワセリン
1.0■POE(25モル)セチ
ルエーテル 2.00グリセリルモノステアレー
ト 1.50防腐剤
0.10香料
0.15@AsL−24S
f)、3[相]没食子酸
1.00精製水
残余(製法)
成分■〜[相]を混合溶解し、同じく混合溶解した、成
分■、■、■、■、■の中へ攪拌混合して乳化した。ホ
モジナイザーにより乳化粒子を整え、その後熱交換器に
て室温まで冷却してW10型クリームを得た。Example 2 (Formulation) Ingredients % Glycerin 5.00 Polyethylene glycol (molecular weight 400) 2.0 Glycyrrhizic acid monoammonium salt 0.1 Allantoin
0.10 chrysanthemine
1.0 ■ Setanol
4.00 Squalane
5.0 ■ Stearic acid
1.0 ■ Beeswax
1.0 [phase] Vaseline
1.0 POE (25 mol) Cetyl ether 2.00 Glyceryl monostearate 1.50 Preservative
0.10 fragrance
0.15@AsL-24S
f), 3 [phase] gallic acid
1.00 purified water
Residue (manufacturing method) Components (1) to [phase] were mixed and dissolved, and stirred and mixed into components (2), (2), (2), (2), and (2), which were also mixed and dissolved, to emulsify. Emulsified particles were prepared using a homogenizer, and then cooled to room temperature using a heat exchanger to obtain W10 type cream.
実施例3
(配合)
成分 %■ポリビ
ニルアルコール 10.0■ポリエチ
レングリコール(分子量400 ) 0.4■グリ
セリン 3.0■エタ
ノール(95%)8.O
■シアニジン *i o、s
■ASL−24S O,
5■防腐剤 0.1
■香料 0.1
■楕製水 残余*1
:クリサンテミンを酸(例えば10%塩酸)で加水分解
して得られるシアニジン。Example 3 (Formulation) Ingredients % ■ Polyvinyl alcohol 10.0 ■ Polyethylene glycol (molecular weight 400) 0.4 ■ Glycerin 3.0 ■ Ethanol (95%) 8. O ■Cyanidin *i o, s
■ASL-24S O,
5■Preservative 0.1
■Fragrance 0.1
■Oval water residual *1
: Cyanidin obtained by hydrolyzing chrysanthemine with an acid (for example, 10% hydrochloric acid).
(製法)
室温で成分■〜■を混合溶解し、これを成分■、■、■
および■を80℃で混合熔解した中に攪拌添加した後、
室温まで放冷してバックを得た。(Manufacturing method) Mix and dissolve ingredients ■~■ at room temperature, and add this to ingredients ■, ■, ■
After stirring and adding (1) and (2) into a mixture and melt at 80°C,
A bag was obtained by cooling to room temperature.
実施例4
(配合)
成分 %■スクワ
ラン 5.0■ワセリ
ン 2.0■ミツ
ロウ 0.5■ソルビ
タンセスキオレイン酸エステル 0.80POE(
20モル)オレイルエーテル 1.2■プロピレ
ングリコール 5.0■クリサンテ
ミン 0.5■エスカロー
ル506 0.2■タンニン
酸 0.3[株]エタ
ノール 10.00香料
通量■防腐剤
通量0楕製水
残余(製法)
上記成分の、■、■、■、■、■及び@を70℃にて攪
拌溶解して油相とした。一方、成分■、■、■及び■を
成分■中に溶解して水相とし70℃に保った。Example 4 (Formulation) Ingredients % ■ Squalane 5.0 ■ Vaseline 2.0 ■ Beeswax 0.5 ■ Sorbitan sesquioleate 0.80 POE (
20 mol) Oleyl ether 1.2 ■ Propylene glycol 5.0 ■ Chrysanthemine 0.5 ■ Escarol 506 0.2 ■ Tannic acid 0.3 [stock] Ethanol 10.00 Fragrance Usage ■ Preservative
Volume 0 oval water
Residue (manufacturing method) The above components (■, ■, ■, ■, ■, and @) were stirred and dissolved at 70°C to obtain an oil phase. On the other hand, components (1), (2), (2) and (2) were dissolved in component (2) to form an aqueous phase and maintained at 70°C.
直前に成分■を水相中へ混入した後、さらに油相を混合
して乳液を得た。Immediately before, component (1) was mixed into the aqueous phase, and then the oil phase was further mixed to obtain an emulsion.
実施例5
(配合)
成分 %■ヒマシ
油 20.0■セチ
ルアルコール 20.0■ミツロ
ウ 5.0■キヤンデ
リラロウ 30.0■クリサン
テミン 2.0■ASL
−24S O,5■
スクワラン 13.0■カ
ルナバロウ 5.0■
顔料 5・O[相
]香料 通量(
製法)
成分■〜[相]を80℃にて混合溶解し、型に流し込ん
で室温まで放冷した後、型から取り出して棒状口紅を得
た。Example 5 (Composition) Ingredients % ■ Castor oil 20.0 ■ Cetyl alcohol 20.0 ■ Beeswax 5.0 ■ Candelilla wax 30.0 ■ Chrysanthemine 2.0 ■ ASL
-24S O, 5■
Squalane 13.0 ■ Carnauba wax 5.0 ■
Pigment 5・O [phase] Fragrance amount (
Manufacturing method) Ingredients (1) to [phase] were mixed and dissolved at 80°C, poured into a mold, allowed to cool to room temperature, and then taken out from the mold to obtain a lipstick stick.
発明の効果
本発明の皮膚外用剤は、皮膚に対して、なめらかな使用
感、保湿効果、柔軟効果、賦活効果を与え、皮膚ヒアル
ロン酸量を増加させ、皮膚にはり、つやを与え、肌荒れ
の防止及び改善に極めて有用である。Effects of the Invention The skin external preparation of the present invention provides a smooth feeling of use, a moisturizing effect, a softening effect, and a revitalizing effect on the skin, increases the amount of hyaluronic acid in the skin, gives firmness and luster to the skin, and reduces rough skin. Extremely useful for prevention and improvement.
また、本発明の必須成分の1つであるクリサンテミンな
どのアントシアニン類又はそのアグリコンであるアント
シアニジン類は天然色素であり安全性も高い皮膚外用剤
である。Furthermore, anthocyanins such as chrysanthemine, which are one of the essential components of the present invention, or anthocyanidins, which are aglycones thereof, are natural pigments and are highly safe external preparations for skin.
Claims (1)
シアニジン類からなる群から選ばれた少なくとも1種を
含む皮膚外用剤。 2、アントシアニン類及び/又はアントシアニジン類の
配合量が0.0001〜30重量%である特許請求の範
囲第1項記載の皮膚外用剤。 3、紫外線吸収剤及び/又は酸化防止剤を含有する特許
請求の範囲第1項記載の皮膚外用剤。 4、アントシアニン類及び/又はアントシアニジン類が
高等植物の培養細胞から得られる特許請求の範囲第1項
記載の皮膚外用剤。 5、アントシアニン類及び/又はアントシアニジン類が
ユーホルビア属植物の培養細胞から得られる特許請求の
範囲第1項記載の皮膚外用剤。 6、アントシアニン類及び/又はアントシアニジン類が
ユーホルビア属植物ハナキリンの培養細胞から得られる
特許請求の範囲第1項記載の皮膚外用剤。 7、前記アントシアニン類がユーホルビア属植物ハナキ
リンの培養細胞から得られるクリサンテミンである特許
請求の範囲第1項記載の皮膚外用剤。 8、前記アントシアニジン類がユーホルビア属植物ハナ
キリンの培養細胞から得られるシアニジンである特許請
求の範囲第1項記載の皮膚外用剤。[Scope of Claims] 1. An external preparation for skin containing at least one member selected from the group consisting of anthocyanins and anthocyanidins which are anthocyanins and their aglycones. 2. The external preparation for skin according to claim 1, wherein the amount of anthocyanins and/or anthocyanidins is 0.0001 to 30% by weight. 3. The external preparation for skin according to claim 1, which contains an ultraviolet absorber and/or an antioxidant. 4. The skin external preparation according to claim 1, wherein the anthocyanins and/or anthocyanidins are obtained from cultured cells of higher plants. 5. The skin external preparation according to claim 1, wherein the anthocyanins and/or anthocyanidins are obtained from cultured cells of a plant of the genus Euphorbia. 6. The skin external preparation according to claim 1, wherein the anthocyanins and/or anthocyanidins are obtained from cultured cells of Hanakirin, a plant of the genus Euphorbia. 7. The skin external preparation according to claim 1, wherein the anthocyanin is chrysanthemin obtained from cultured cells of Hanakirin, a plant of the genus Euphorbia. 8. The skin external preparation according to claim 1, wherein the anthocyanidin is cyanidin obtained from cultured cells of Hanakirin, a plant of the genus Euphorbia.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60187188A JPS6248611A (en) | 1985-08-28 | 1985-08-28 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60187188A JPS6248611A (en) | 1985-08-28 | 1985-08-28 | External preparation for skin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6248611A true JPS6248611A (en) | 1987-03-03 |
Family
ID=16201645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60187188A Pending JPS6248611A (en) | 1985-08-28 | 1985-08-28 | External preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6248611A (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04107106U (en) * | 1991-02-28 | 1992-09-16 | マツダ株式会社 | vehicle suspension device |
EP0674897A2 (en) * | 1994-03-31 | 1995-10-04 | Shiseido Company Limited | Hair composition |
FR2768343A1 (en) * | 1997-09-18 | 1999-03-19 | Oreal | Use of chrysanthemum extract to increase melanogenesis in cosmetic and pharmaceutical compositions |
JP2001278775A (en) * | 2000-01-26 | 2001-10-10 | Kose Corp | Skin care preparation |
WO2001087259A1 (en) * | 2000-05-18 | 2001-11-22 | L'oreal | Anti-pollution composition based on anthocyanic pigments |
JP2001354576A (en) * | 2000-06-08 | 2001-12-25 | Kao Corp | Hair cosmetic |
EP1172092A1 (en) * | 2000-07-12 | 2002-01-16 | L'oreal | Skin dyeing compositions containing at least an uv filter and a non substituted in position 3 flavylium salt |
FR2827512A1 (en) * | 2001-07-17 | 2003-01-24 | Oreal | The use of an amphiphilic polymer of 2-acrylamido-2-methyl propane sulfonic acid to improve the stability and coloring capability of artificial suntanning compositions containing a flavylium salt |
US6726940B2 (en) | 1997-09-18 | 2004-04-27 | Societe L'oreal S.A. | Use of at least one extract of the genus chrysanthemum for assisting skin and/or hair pigmentation |
WO2006019114A1 (en) * | 2004-08-18 | 2006-02-23 | Nichirei Foods Inc. | Skin-lightening agent containing polyphenol compound |
JP2007246492A (en) * | 2006-03-20 | 2007-09-27 | Noevir Co Ltd | Humectant, cell activator and antioxidant |
JP2009256328A (en) * | 2008-03-28 | 2009-11-05 | Taisho Pharmaceutical Co Ltd | Composition for external application for aerosol containing anthocyanin |
JP2010070487A (en) * | 2008-09-18 | 2010-04-02 | Fancl Corp | Mif secretion inhibitor |
JP2010189288A (en) * | 2009-02-16 | 2010-09-02 | Toyo Hakko:Kk | Keratinocyte growth inhibitor, and treating agent or preventive and cosmetic of skin disease containing the same |
US7863248B2 (en) | 2003-10-30 | 2011-01-04 | Meiji Seika Kaisha, Ltd. | Tyrosinase activity inhibitor and ameliorant for facial blood flow |
JP2011184346A (en) * | 2010-03-08 | 2011-09-22 | Maruzen Pharmaceut Co Ltd | Hyaluronic acid production promoter and cosmetic |
US8158164B2 (en) | 2009-02-23 | 2012-04-17 | Conopco, Inc. | Edible composition for treating cutaneous signs of ageing |
CN102579285A (en) * | 2012-03-26 | 2012-07-18 | 陕西语泽化妆品有限公司 | Fibrinolytic protein peptide canthus wrinkle removing cream and preparation method thereof |
JP2014521698A (en) * | 2011-08-05 | 2014-08-28 | ステムテック インターナショナル, インコーポレイテッド | Skin care composition containing a combination of natural ingredients |
CN105769620A (en) * | 2016-03-29 | 2016-07-20 | 高小娜 | Lemon color-changing lipstick |
-
1985
- 1985-08-28 JP JP60187188A patent/JPS6248611A/en active Pending
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04107106U (en) * | 1991-02-28 | 1992-09-16 | マツダ株式会社 | vehicle suspension device |
EP0674897A2 (en) * | 1994-03-31 | 1995-10-04 | Shiseido Company Limited | Hair composition |
EP0674897A3 (en) * | 1994-03-31 | 1996-03-27 | Shiseido Co Ltd | Hair composition. |
US6726940B2 (en) | 1997-09-18 | 2004-04-27 | Societe L'oreal S.A. | Use of at least one extract of the genus chrysanthemum for assisting skin and/or hair pigmentation |
FR2768343A1 (en) * | 1997-09-18 | 1999-03-19 | Oreal | Use of chrysanthemum extract to increase melanogenesis in cosmetic and pharmaceutical compositions |
WO1999013856A1 (en) * | 1997-09-18 | 1999-03-25 | L'oreal | Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation |
AU739954B2 (en) * | 1997-09-18 | 2001-10-25 | L'oreal | Use of at least an extract of the genus chrysanthemum for assisting skin and/or hair pigmentation |
JP2001278775A (en) * | 2000-01-26 | 2001-10-10 | Kose Corp | Skin care preparation |
WO2001087259A1 (en) * | 2000-05-18 | 2001-11-22 | L'oreal | Anti-pollution composition based on anthocyanic pigments |
FR2809003A1 (en) * | 2000-05-18 | 2001-11-23 | Oreal | The use of anthocyanins in cosmetic compositions to protect against pollution, especially toxic gases and ozone |
JP4485020B2 (en) * | 2000-06-08 | 2010-06-16 | 花王株式会社 | Hair cosmetics |
JP2001354576A (en) * | 2000-06-08 | 2001-12-25 | Kao Corp | Hair cosmetic |
EP1172092A1 (en) * | 2000-07-12 | 2002-01-16 | L'oreal | Skin dyeing compositions containing at least an uv filter and a non substituted in position 3 flavylium salt |
FR2811554A1 (en) * | 2000-07-12 | 2002-01-18 | Oreal | COMPOSITION COMPRISING AT LEAST ONE UV FILTER AND ONE NON-SUBSTITUTED FLAVYLIUM SALT IN POSITION 3 FOR SKIN COLORING AND USES |
FR2827512A1 (en) * | 2001-07-17 | 2003-01-24 | Oreal | The use of an amphiphilic polymer of 2-acrylamido-2-methyl propane sulfonic acid to improve the stability and coloring capability of artificial suntanning compositions containing a flavylium salt |
WO2003007910A1 (en) * | 2001-07-17 | 2003-01-30 | L'oreal | Compositions comprising compounds of flavylium salt type unsubstituted in position 3 for skin colouring and uses |
US7863248B2 (en) | 2003-10-30 | 2011-01-04 | Meiji Seika Kaisha, Ltd. | Tyrosinase activity inhibitor and ameliorant for facial blood flow |
WO2006019114A1 (en) * | 2004-08-18 | 2006-02-23 | Nichirei Foods Inc. | Skin-lightening agent containing polyphenol compound |
EP1787624A4 (en) * | 2004-08-18 | 2011-01-12 | Nichirei Foods Inc | Skin-lightening agent containing polyphenol compound |
JP2007246492A (en) * | 2006-03-20 | 2007-09-27 | Noevir Co Ltd | Humectant, cell activator and antioxidant |
JP2009256328A (en) * | 2008-03-28 | 2009-11-05 | Taisho Pharmaceutical Co Ltd | Composition for external application for aerosol containing anthocyanin |
JP2010070487A (en) * | 2008-09-18 | 2010-04-02 | Fancl Corp | Mif secretion inhibitor |
JP2010189288A (en) * | 2009-02-16 | 2010-09-02 | Toyo Hakko:Kk | Keratinocyte growth inhibitor, and treating agent or preventive and cosmetic of skin disease containing the same |
US8158164B2 (en) | 2009-02-23 | 2012-04-17 | Conopco, Inc. | Edible composition for treating cutaneous signs of ageing |
JP2011184346A (en) * | 2010-03-08 | 2011-09-22 | Maruzen Pharmaceut Co Ltd | Hyaluronic acid production promoter and cosmetic |
JP2014521698A (en) * | 2011-08-05 | 2014-08-28 | ステムテック インターナショナル, インコーポレイテッド | Skin care composition containing a combination of natural ingredients |
CN102579285A (en) * | 2012-03-26 | 2012-07-18 | 陕西语泽化妆品有限公司 | Fibrinolytic protein peptide canthus wrinkle removing cream and preparation method thereof |
CN105769620A (en) * | 2016-03-29 | 2016-07-20 | 高小娜 | Lemon color-changing lipstick |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6248611A (en) | External preparation for skin | |
US5073545A (en) | Agent containing an ellagic acid series compound for external application and use thereof | |
EP1500385B1 (en) | Method of foam stabilization for foam cosmetic | |
JPH08119825A (en) | Hydroxytyrosol, application for skin external medicine or bathing agent | |
JPS63192705A (en) | External agent for skin | |
JPH0930946A (en) | Beautifying and whitening dermal preparation for external use | |
WO1998031338A1 (en) | Compositions promoting collagen production | |
JPH04338313A (en) | Cosmetic | |
JPH049316A (en) | Whitening cosmetic | |
JPH0532556A (en) | Skin agent for external use | |
JPH1029927A (en) | Antiaging agent | |
JP4828077B2 (en) | Topical skin preparation | |
JP2001114636A (en) | Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion | |
JP3480954B2 (en) | External preparation for skin | |
JPH11246337A (en) | Antiaging agent | |
JPH0812561A (en) | Beautifying and whitening skin preparation for external use | |
JPS6210006A (en) | Skin cosmetic | |
JP3101090B2 (en) | External preparation for skin | |
JP2000212057A (en) | Cosmetic composition | |
JPS5948808B2 (en) | cosmetics | |
JP2781626B2 (en) | Solubilized transparent cosmetic | |
JPH11106347A (en) | Immunoactivator | |
JP2002193820A (en) | Skin care preparation and skin care preparation composition | |
JPS60116616A (en) | Cosmetic | |
JP2003335628A (en) | Skin care preparation for external use |